Inventor · disambiguated record
Xianghong Wang
Also filed as: WANG XIANGHONG
25 granted patents·7 pending applications·334 citations·filing 2003–2024
96Inventor score
Top patents by PatentIndex Score
32 records- 0197US9562061B2Compounds that inhibit MCL-1 proteinAMGEN INC·Filed 2015·Granted Feb 7, 2017·39 cites·30 claims
- 0296US11117886B2Methods and intermediates for preparing therapeutic compoundsGILEAD SCIENCES INC·Filed 2020·Granted Sep 14, 2021·15 cites·22 claims
- 0394US7897619B2Heterocyclic modulators of PKBAMGEN INC·Filed 2008·Granted Mar 1, 2011·42 cites·41 claims
- 0494US7514566B2Thiazole compounds and methods of useAMGEN INC·Filed 2007·Granted Apr 7, 2009·38 cites·48 claims
- 0593US10696657B2Methods and intermediates for preparing therapeutic compoundsGILEAD SCIENCES INC·Filed 2019·Granted Jun 30, 2020·22 cites·21 claims
- 0693US7919504B2Thiadiazole modulators of PKBAMGEN INC·Filed 2008·Granted Apr 5, 2011·30 cites·16 claims
- 0792US11344565B2Methods for the preparation of ribosidesGILEAD SCIENCES INC·Filed 2015·Granted May 31, 2022·19 cites·19 claims
- 0892US8623885B2Fused tricyclic dual inhibitors of CDK 4/6 and FLT3CHEN XIAOQI·Filed 2012·Granted Jan 7, 2014·44 cites·35 claims
- 0991US10100063B2Compounds that inhibit Mcl-1 proteinAMGEN INC·Filed 2016·Granted Oct 16, 2018·8 cites·12 claims
- 1091US7579347B2Vanilloid receptor ligands and their use in treatmentsAMGEN INC·Filed 2005·Granted Aug 25, 2009·17 cites·9 claims
- 1191US7429608B2Benzo[d]imidazol analogs as vanilloid receptor ligands and their use in treatmentsAMGEN INC·Filed 2006·Granted Sep 30, 2008·11 cites·15 claims
- 1286US11760746B2Methods and intermediates for preparing therapeutic compoundsGILEAD SCIENCES INC·Filed 2021·Granted Sep 19, 2023·1 cites·14 claims
- 1386US10494381B2Compounds that inhibit Mcl-1 proteinAMGEN INC·Filed 2018·Granted Dec 3, 2019·3 cites·13 claims
- 1484US7053088B2Vanilloid receptor ligands and their use in treatmentsAMGEN INC·Filed 2003·Granted May 30, 2006·19 cites·22 claims
- 1584US2025100999A1Methods and intermediates for preparing therapeutic compoundsGILEAD SCIENCES INC·Filed 2024·Application pending·0 cites
- 1682US7396831B2Vanilloid receptor ligands and their use in treatmentsAMGEN INC·Filed 2005·Granted Jul 8, 2008·5 cites·21 claims
- 1782US7335672B2Vanilloid receptor ligands and their use in treatmentsAMGEN INC·Filed 2005·Granted Feb 26, 2008·6 cites·12 claims
- 1881US11306107B2Compounds that inhibit MCL-1 proteinAMGEN INC·Filed 2017·Granted Apr 19, 2022·2 cites·11 claims
- 1978US8026241B2Vanilloid receptor ligands and their use in treatmentsAMGEN INC·Filed 2009·Granted Sep 27, 2011·3 cites·17 claims
- 2078US7544803B2Vanilloid receptor ligands and their use in treatmentsAMGEN INC·Filed 2005·Granted Jun 9, 2009·3 cites·4 claims
- 2178US7301022B2Vanilloid receptor ligands and their use in treatmentsAMGEN INC·Filed 2006·Granted Nov 27, 2007·4 cites·11 claims
- 2276US2022354873A1Methods for the preparation of ribosidesGILEAD SCIENCES INC·Filed 2022·Application pending·0 cites
- 2374US10836779B2Compounds that inhibit MCL-1 proteinAMGEN INC·Filed 2018·Granted Nov 17, 2020·0 cites·8 claims
- 2471US8084479B2Thiazole compounds and methods of useZENG QINGPING·Filed 2009·Granted Dec 27, 2011·1 cites·20 claims
- 2566US2020197422A1Methods for the preparation of ribosidesGILEAD SCIENCES INC·Filed 2019·Application pending·0 cites
- 2664US7582761B2Vanilloid receptor ligands and their use in treatmentsAMGEN INC·Filed 2003·Granted Sep 1, 2009·2 cites·20 claims
- 2764US2009264424A1Vanilloid receptor ligands and their use in treatmentsAMGEN INC·Filed 2009·Application pending·0 cites
- 2863US9359355B2Fused tricyclic dual inhibitors of CDK 4/6 and FLT3AMGEN INC·Filed 2013·Granted Jun 7, 2016·0 cites·14 claims
- 2954US7524874B2Vanilloid receptor ligands and their use in treatmentsAMGEN INC·Filed 2005·Granted Apr 28, 2009·0 cites·19 claims
- 3054US2016368933A1Fused tricyclic dual inhibitors of cdk 4/6 and flt3AMGEN INC·Filed 2016·Application pending·0 cites
- 3144US2006241296A1Vanilloid receptor ligands and their use in treatmentsDOHERTY ELIZABETH M·Filed 2006·Application pending·0 cites
- 3237US2011263647A1Fluoroisoquinoline substituted thiazole compounds and methods of useAMGEN INC·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Xianghong Wang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →